Xiuping Liu Selected Research

Hemay005

6/2018

Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC-MS/MS and its application to a PK study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiuping Liu Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 11/2007
22	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
10	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2011
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2014
3	Inflammation (Inflammations) 10/2022 - 02/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 09/2012
3	Atherosclerosis 01/2022 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2018
3	Carcinogenesis 04/2018 - 09/2007
3	Inflammatory Breast Neoplasms 01/2018 - 04/2016
3	Hypoxia (Hypoxemia) 05/2016 - 06/2011
2	Atherosclerotic Plaque (Atheroma) 10/2022 - 01/2022
2	Non-alcoholic Fatty Liver Disease 07/2022 - 05/2016
2	Fibrosis (Cirrhosis) 07/2022 - 05/2016
2	Triple Negative Breast Neoplasms 01/2022 - 01/2014
2	Papillary Thyroid Cancer 01/2021 - 03/2018
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2012
2	Infections 03/2020 - 01/2016
2	Colitis 10/2018 - 12/2011
2	Adenocarcinoma 01/2018 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 09/2017 - 04/2015
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 10/2014 - 09/2012
2	Carcinoma (Carcinomatosis) 07/2014 - 05/2010
1	Endotoxemia 01/2022
1	Eye Infections 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Aarskog Syndrome 09/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 06/2020
1	Virus Diseases (Viral Diseases) 03/2020
1	Body Weight (Weight, Body) 01/2020
1	Arteritis 01/2020
1	Hypertension (High Blood Pressure) 12/2019
1	Dry Eye Syndromes (Dry Eye Syndrome) 09/2019

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2007
15	MicroRNAs (MicroRNA)IBA 01/2018 - 09/2007
7	Biomarkers (Surrogate Marker)IBA 04/2018 - 05/2010
6	Messenger RNA (mRNA)IBA 04/2018 - 08/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2007
4	Pharmaceutical PreparationsIBA 01/2021 - 02/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2013
3	CytokinesIBA 10/2022 - 10/2009
3	intybinIBA 01/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2022 - 09/2015
3	Biological ProductsIBA 01/2021 - 01/2016
3	Indicators and Reagents (Reagents)IBA 04/2018 - 01/2015
3	ParaffinIBA 01/2018 - 09/2014
3	Small Interfering RNA (siRNA)IBA 01/2016 - 05/2010
3	RNA (Ribonucleic Acid)IBA 02/2013 - 01/2012
2	Apolipoproteins E (ApoE)IBA 10/2022 - 01/2022
2	Therapeutic UsesIBA 07/2022 - 01/2022
2	euxanthoneIBA 01/2020 - 01/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2018 - 07/2014
2	Formaldehyde (Formol)FDA Link 01/2018 - 01/2016
2	UbiquitinIBA 05/2016 - 01/2016
2	Oxygen (Dioxygen)IBA 05/2016 - 06/2011
2	Matrix Metalloproteinases (MMPs)IBA 02/2016 - 01/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016 - 09/2008
2	NucleotidesIBA 09/2015 - 01/2015
2	Estrogen ReceptorsIBA 09/2014 - 01/2012
2	Epidermal Growth Factor (EGF)IBA 09/2014 - 01/2014
2	Tamoxifen FDA LinkGeneric 09/2013 - 01/2012
1	LipidsIBA 10/2022
1	Metformin (Glucophage)FDA LinkGeneric 07/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	CholesterolIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	SaltsIBA 01/2022
1	Terpenes (Terpenoids)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021
1	Long Noncoding RNAIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	SesquiterpenesIBA 01/2021
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2021
1	LactonesIBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Cytoplasmic DyneinsIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 01/2021
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	Dynamins (Dynamin)IBA 06/2020
1	Interleukin-10 (Interleukin 10)IBA 03/2020
1	LipopolysaccharidesIBA 03/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	Gadolinium DTPA (Magnevist)FDA Link 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	protocatechuic acidIBA 01/2020
1	GadoliniumIBA 01/2020
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2019
1	HomocysteineIBA 12/2019
1	SuspensionsIBA 09/2019

Therapy/Procedure

15	Therapeutics 01/2022 - 05/2009
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2014
2	Neoadjuvant Therapy 01/2018 - 09/2014
2	Radiotherapy 01/2018 - 01/2017
1	Transplantation 01/2021